ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,836.22
      0.16%
      US Tech 100
      20,327.20
      0.20%
      Dow Jones
      42,297.12
      0.86%
      Brent Oil
      79.785
      -0.62%
      Bitcoin
      94,839.46
      0.35%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. CRISPR Therapeutics AG (CRSP)

      7. CRISPR Therapeutics AG (CRSP) News

      CRISPR Therapeutics AG

      CRISPR Therapeutics AG (CRSP)

      NASDAQ
      38.85
      -0.84
      (-2.12%)
      Closed January 14 4:00PM
      Delayed by 15 minutes
      39.15
      0.30
      (0.77%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      CRSP News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 27 2024
      CRSP (-2.12%)

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
      Edgar (US Regulatory)
      December 10 2024
      CRSP (-2.12%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      December 04 2024
      CRSP (-2.12%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 13 2024
      CRSP (-2.12%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 05 2024
      CRSP (-2.12%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 05 2024
      CRSP (-2.12%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      October 18 2024
      CRSP (-2.12%)

      CRSP Discussion

      View Posts
      jondoeuk jondoeuk 5 hours ago
      Anticipated 2025 milestones https://www.globenewswire.com/news-release/2025/01/13/3008308/0/en/CRISPR-Therapeutics-Highlights-Strategic-Priorities-and-Anticipated-2025-Milestones.html
      👍️0
      jondoeuk jondoeuk 5 hours ago
      Link to the webcast https://jpmorgan.metameetings.net/events/healthcare25/sessions/58421-crispr-therapeutics/webcast/general_signin?gpu_only=true&kiosk=true+%5Bjpmorgan.metameetings.net%5D
      👍️0
      jondoeuk jondoeuk 5 days ago
      They will present at the 43rd Annual J.P. Morgan Healthcare Conference (Jan 14, at 2:15 PM PST).
      👍️ 1
      PonkenPlonken PonkenPlonken 1 month ago
      cheap cheap
      👍️ 1
      jondoeuk jondoeuk 1 month ago
      The PR https://www.globenewswire.com/news-release/2024/12/09/2993974/0/en/CRISPR-Therapeutics-Presents-Data-at-the-2024-American-Society-of-Hematology-ASH-Annual-Meeting.html

      Poster https://ir.crisprtx.com/static-files/12114290-21a6-4544-9cb7-de4fe2852e94
      👍️0
      PonkenPlonken PonkenPlonken 1 month ago
      Neglected ugly duckling. $NTLA, $VERV & $CRBU now do trials outside of the US.... Maybe sentiment change is on the horizon -- see below

      "The CBER director also apologized for “mistakes” in how the FDA handled early work for in vivo gene therapies, which “led to offshoring of some of the trials.”"
      https://endpts.com/fda-vaccine-chief-peter-marks-pledges-to-stay-as-long-as-hes-welcome/#:~:text=The%20CBER%20director%20also%20apologized,%E2%80%9Cit%20is%20really%20important.%E2%80%9D

      CHEAP CHEAP
      SRPT and BMS announcing nice CRISPR deals with ARWR and PRME should help this too!
      👍️0
      jondoeuk jondoeuk 1 month ago
      CTX130 data in R/R T-cell lymphomas (peripheral T-cell lymphoma or cutaneous T-cell lymphoma) https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00508-4/abstract

      The ORR was 46.2%. Of those treated at DL3 and higher, the ORR was 51.6%.
      👍️ 1
      PonkenPlonken PonkenPlonken 2 months ago
      so so so undervalued and misunderstood i believe...... frankly just cheap
      https://x.com/RNAiAnalyst/status/1859876294487363651
      👍️ 1
      jondoeuk jondoeuk 2 months ago
      They now have the ability to put in eight to nine edits. So it is a single cassette that expresses the CAR, can express a cytokine and has an shRNA-like approach to knock down genes. So there's no theoretical limit as to the number of edits, but there may be marginal utility beyond a certain point.

      Hopefully, they look to improve donor selection, cell selection and manufacturing, as all could increase efficacy.
      👍️ 1
      jondoeuk jondoeuk 2 months ago
      ASH abstract https://ash.confex.com/ash/2024/webprogram/Paper203563.html
      👍️0
      jondoeuk jondoeuk 2 months ago
      Q3 business update and financial results https://www.globenewswire.com/news-release/2024/11/05/2974996/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2024-Financial-Results.html
      👍️0
      Monksdream Monksdream 2 months ago
      CRSP 10Q 11/5
      👍️0
      Monksdream Monksdream 3 months ago
      CRSP under $50
      👍️0
      jondoeuk jondoeuk 3 months ago
      OT: In this Dr. Urnov, PhD, laid out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies https://www.liebertpub.com/doi/10.1089/crispr.2024.0082
      👍️ 1
      TechandBio TechandBio 4 months ago
      CRSP will climb tremendously over the years.
      SMMT went from $1.00-30.00+ this year cancer drug superior to Mercks Keytruda
      ICCM company being over looked that kills cancers by freezing them 97% non recurrence rate for breast cancer after 5 years and superior data to lung cancer safe cryoblation is done in less than hour.
      https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html

      https://www.prnewswire.com/il/news-releases/icecure-medical-reports-positive-topline-results-from-ice3-cryoablation-breast-cancer-study-achievement-of-96-39-recurrence-free-rate-brings-company-one-step-closer-to-providing-women-a-non-surgical-alternative-to-lumpectomy-302092712.html
      👍️0
      Monksdream Monksdream 4 months ago
      Buy range again thanks a bunch
      👍️0
      Monksdream Monksdream 4 months ago
      Buy range again thanks a bunch
      👍️0
      OldAIMGuy OldAIMGuy 4 months ago
      Hi MD,
      Here's a little longer view:


      This might also be a cyclical low here. But, most of 2024 has shown severe distribution of shares until about the last month. That, at least, seems to be flattening out.
      Best wishes,
      OAG
      👍️0
      Monksdream Monksdream 4 months ago
      CRSP trend since February remains bearish
      👍️0
      jondoeuk jondoeuk 5 months ago
      Q2 results https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200100452.html
      👍️0
      lambchops lambchops 5 months ago
      Hey Monk, Hopefully you bought some shares on Friday@ Sold at 10% discount!

      LC

      CRISPR!!!
      👍️0
      Monksdream Monksdream 6 months ago
      CRSP under $75
      👍️0
      TechandBio TechandBio 6 months ago
      Crispr added some $120 Vertical debit spreads in 2026

      $CRSP
      👍️ 1
      axelvento axelvento 7 months ago
      I agree.....solid company$$$$$$$$
      👍️0
      Monksdream Monksdream 7 months ago
      It may take some time for CRSP returns to a $200 price tag
      The same could be said for hundreds of other stocks that soared during Covid mania
      Since then the stock has rallied from low points
      With all that money the company has to do incredible things with its biotechnology the stock isn’t going to zero
      👍️ 1
      axelvento axelvento 8 months ago
      Strong balance sheet with approximately $2.1 billion in cash, cash equivalents, and marketable securities as of March 31, 2024

      https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000059.html
      👍️0
      jondoeuk jondoeuk 8 months ago
      (OT): A new AI paper from Princeton and Stanford https://www.biorxiv.org/content/10.1101/2024.04.25.591003v2.full

      CRISPR-GPT demonstrated a marked improvement in gene-editing experiments, increasing the accuracy of target gene modifications by up to 30% compared to conventional methods. In validation tests, it achieved a specificity rate exceeding 95%, with a significant reduction in off-targets. The system also reduced the time required to design and plan experiments by approximately 40%, streamlining the workflow for researchers.
      👍️0
      jondoeuk jondoeuk 8 months ago
      Business Update and Q1 Financial Results https://uk.finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200000300.html
      👍️0
      jondoeuk jondoeuk 8 months ago
      Highlights (plus new programs utilising in vivo gene editing) https://finance.yahoo.com/news/crispr-therapeutics-highlights-asgct-oral-110000066.html
      👍️0
      jondoeuk jondoeuk 9 months ago
      https://www.globenewswire.com/news-release/2024/04/22/2867236/0/en/CRISPR-Therapeutics-to-Present-Oral-Presentation-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-2024-Annual-Meeting.html

      EDIT is also pursuing myocilin-related glaucoma https://www.globenewswire.com/news-release/2024/04/22/2867244/0/en/Editas-Medicine-to-Present-Pre-clinical-Data-Demonstrating-Progression-of-in-vivo-Medicines-Pipeline-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting.html
      👍️0
      OldAIMGuy OldAIMGuy 9 months ago
      StockCharts 3 year history with 20% ZigZag reversals................



      CRSP seems to be suffering from lack of 'sponsorship' in that the stock has not shown "accumulation" trend along with the price rally since last year's October Low. There's been volume, but not accumulation bias.

      Best wishes,
      OAG
      👍️0
      OldAIMGuy OldAIMGuy 9 months ago
      Hi MD,
      CRSP is now down around 1/3 from its February high. The price is where I usually start to accumulate more shares.

      Best wishes,
      OAG
      👍️0
      Monksdream Monksdream 9 months ago
      CRSP over $30
      👍️0
      jondoeuk jondoeuk 9 months ago
      Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-american-society-120000624.html
      👍️0
      Monksdream Monksdream 11 months ago
      CRSP new 52 week high
      👍️0
      Monksdream Monksdream 11 months ago
      Early Barchart 100
      https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
      👍️0
      Monksdream Monksdream 11 months ago
      CRSP new 52 week high
      👍️ 1
      Monksdream Monksdream 11 months ago
      CRSP new 52 week high
      👍️ 1
      jondoeuk jondoeuk 11 months ago
      They entered into an investment agreement for the sale of ~$280 million of its shares to a select group of institutional investors in a registered direct offering, at $71.5 apiece. The financing is being led by EcoR1 Capital and SR One with participation from existing investors and a healthcare specialist investor https://finance.yahoo.com/news/crispr-therapeutics-announces-280-million-133000932.html
      👍️0
      jondoeuk jondoeuk 11 months ago
      EU approval https://finance.yahoo.com/news/european-commission-approves-first-crispr-065900771.html
      👍️ 1
      Monksdream Monksdream 11 months ago
      Didn’t tank like BLUE
      Recovered


      More analysis from Nanolyze

      👍️0
      Monksdream Monksdream 11 months ago
      So there has been some discussion since my last post
      More in this podcast
      🌈 1 🍆 1
      jondoeuk jondoeuk 12 months ago
      Around two months ahead of expectations https://www.globenewswire.com/news-release/2024/01/16/2810298/0/en/CRISPR-Therapeutics-Announces-U-S-Food-and-Drug-Administration-FDA-Approval-of-CASGEVY-exagamglogene-autotemcel-for-the-Treatment-of-Transfusion-Dependent-Beta-Thalassemia.html
      👍️ 1
      jondoeuk jondoeuk 1 year ago
      Strategic Priorities and 2024 Outlook https://finance.yahoo.com/news/crispr-therapeutics-highlights-strategic-priorities-120000043.html
      👍️0
      jondoeuk jondoeuk 1 year ago
      Webcast link https://jpmorgan.metameetings.net/events/healthcare24/sessions/49607-crispr-therapeutics-inc/webcast/general_signin?gpu_only=true&kiosk=true
      👍️ 1
      jondoeuk jondoeuk 1 year ago
      Upcoming https://uk.finance.yahoo.com/news/crispr-therapeutics-present-42nd-annual-133000024.html
      👍️0
      JJ8 JJ8 1 year ago
      Good morning OAG,

      Surprising and interesting. Share price sudden "jack-rabbit" moves in quick price reversals. The technical picture for today changed from positive breakout yesterday to "High Pole Warning" with sudden drop in price. Apparently the dominating group of participants seem to dictate this pace a bit unusual and different from other stocks. Yet it offers opportunity for profit once one has a good plan and strategy.

      Good you have a plan and strategy for your preferred limits and ranges for your trading. Let's see how it goes. Have fun & GLTY
      👍️ 1
      OldAIMGuy OldAIMGuy 1 year ago
      Good morning JJ8,

      It needs to crest $85 or better to get me interested in reducing my share inventory. A drop to $57 will trigger an addition of 12% to share count.

      I'd like to see it crest $72 and maintain that price right now.

      Best wishes,
      OAG
      👍️0
      JJ8 JJ8 1 year ago
      CRSP share price Double Top Breakout today on 19-Dec-2023. Happy Holidays & GLTA
      👍️0
      Monksdream Monksdream 1 year ago
      Oscar Wilde once observed that a cynic knows the price of everything and the value of nothing
      👍️0

      Your Recent History

      NASDAQ
      CRSP
      CRISPR Therapeutics
      BIT
      UC41K8
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads